Dual Chamber Syringes versus Vials: Is there a clear choice?

 The number of drugs supplied in lyophilized form has been growing at an increased rate over the past ten years, mirroring the increase in the number of complex biologics entering the market.  However, biologics present a challenge to both the manufacturer and the end-user. In liquid form they are often unstable due to their complex structure and composition. As such, they must be manufactured using the highly specialized process of lyophilization.

Dual-chamber technology can provide an effective alternative to the standard  drug delivery system by combining lyophilized drug and diluent in a closed system, and enabling reconstitution in a few simple steps. At the same time, this technology can help set a product apart from its competitors and play an important role in its lifecycle management strategy at initial launch, or add value to a brand once it is established in the market. Interested in learning more about the differences between dual-chamber syringes and vials, as well as the process of lyophilization? Check out the, BioProcess International's Online Educational Series webinar entitled: "Dual-Chamber Syringes vs. Vials" featuring Dr. David Brett, Product and Service Manager, and Joerg Zimmermann, Director Process Development and Implementation, both of Vetter.  To access the webinar, click here.